Natus Medical Incorporated
NTUS · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $806 | $673 | $1,112 | $908 |
| - Cash | $76 | $82 | $63 | $56 |
| + Debt | $12 | $56 | $55 | $104 |
| Enterprise Value | $742 | $646 | $1,103 | $956 |
| Revenue | $473 | $416 | $495 | $531 |
| % Growth | 13.9% | -16.1% | -6.7% | – |
| Gross Profit | $274 | $217 | $292 | $304 |
| % Margin | 57.8% | 52.1% | 58.9% | 57.3% |
| EBITDA | $49 | $10 | $14 | $8 |
| % Margin | 10.4% | 2.3% | 2.9% | 1.6% |
| Net Income | $13 | -$17 | -$16 | -$23 |
| % Margin | 2.8% | -4% | -3.2% | -4.3% |
| EPS Diluted | 0.39 | -0.49 | -0.47 | -0.69 |
| % Growth | 179.6% | -4.3% | 31.9% | – |
| Operating Cash Flow | $64 | $34 | $60 | $33 |
| Capital Expenditures | -$4 | -$9 | -$5 | -$9 |
| Free Cash Flow | $60 | $26 | $55 | $24 |